ChemoCentryx

ChemoCentryx is a biopharmaceutical company focused on the discovery, development, and commercialization of oral therapies for the treatment of autoimmune diseases, inflammatory conditions, and cancer, with a primary focus on orphan and rare diseases. We are committed to serving patients and dedicated to delivering drugs that address unmet needs in current therapeutic areas.